These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4688430)

  • 21. MAO activity, serotonin metabolism and aggregation of platelets from migraine patients. A preliminary study.
    Kovács K; Tóthfalusi L; Hermán F; Magyar K
    Pol J Pharmacol Pharm; 1988; 40(6):691-5. PubMed ID: 3152004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of serotonin by the isolated perfused rat liver--effect of glucuronyl transferase deficiency or monoamine oxidase inhibition.
    Tyce GM; Flock EV; Owen CA
    Biochem Pharmacol; 1968 Aug; 17(8):1543-52. PubMed ID: 4386234
    [No Abstract]   [Full Text] [Related]  

  • 23. Rate of metabolism of adrenaline and 5-hydroxytryptamine by blood platelets.
    Lahovaara S; Paasonen MK; Airaksinen MM
    Ann Med Exp Biol Fenn; 1968; 46(3):453-6. PubMed ID: 5734249
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Tryptophan and serotonin in Down syndrome.
    Lancet; 1974 Dec; 2(7896):1554. PubMed ID: 4140989
    [No Abstract]   [Full Text] [Related]  

  • 25. A correlation of histology and amino acid incorporation studies in Duchenne muscular dystrophy.
    Monckton G; Nihei T
    Neurology; 1969 Apr; 19(4):415-8. PubMed ID: 5813377
    [No Abstract]   [Full Text] [Related]  

  • 26. An enzyme (MAO) defect on the platelets in migraine.
    Sicuteri F; Buffoni F; Anselmi B; Del Bianco PL
    Res Clin Stud Headache; 1970; 3():245-51. PubMed ID: 5527206
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium-activated neutral protease from muscle and platelets of Duchenne muscular dystrophy cases.
    Rabbani N; Moses L; Anandavalli TE; Anandaraj MP
    Clin Chim Acta; 1984 Nov; 143(2):163-8. PubMed ID: 6096040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic hyperserotoninemia on platelet monoamine oxidase activity and serotonin uptake.
    Feldman JM
    Biochem Med; 1979 Jun; 21(3):299-310. PubMed ID: 496921
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of platelet protein phosphorylation in Duchenne muscular dystrophy. Further evidence against the generalised membrane defect theory.
    Nicholson GA; McLeod JG; Sugars JW
    J Neurol Sci; 1984 Apr; 64(1):21-32. PubMed ID: 6737001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superprecipitation and adenosine triphosphatase activity of myosin B in Duchenne muscular dystrophy.
    Furukawa T; Peter JB
    Neurology; 1971 Sep; 21(9):920-4. PubMed ID: 4255122
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipid changes in Duchenne muscular dystrophy.
    Hughes BP
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):658-63. PubMed ID: 5084134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I; Morgan J; Cohen L
    Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)].
    Kowalewski S; Rotthauwe HW
    Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500
    [No Abstract]   [Full Text] [Related]  

  • 35. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.
    Uchino M; Araki S; Miike T; Teramoto H; Nakamura T; Yasutake T
    Muscle Nerve; 1989 Dec; 12(12):1009-16. PubMed ID: 2695839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868
    [No Abstract]   [Full Text] [Related]  

  • 38. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P; Lafourcade G; Jerome H
    Biomedicine; 1974 Oct; 21(10):426-8. PubMed ID: 4281668
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
    Neville HE; Harrold S
    Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished activity of platelet monoamine oxidase in Down's syndrome.
    Benson PF; Southgate J
    Am J Hum Genet; 1971 Mar; 23(2):211-4. PubMed ID: 4253914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.